Quantcast
Last updated on April 16, 2014 at 13:48 EDT

Latest Anthrax Stories

2011-10-04 11:12:17

The Institute of Medicine (IOM) released a report last Friday that provides guidance to U.S. public health officials to develop plans to pre-position antibiotics that can be distributed to the general public in the case of a large-scale anthrax attack. Tia Powell, M.D., director of the Montefiore Einstein Center for Bioethics and the Einstein Cardozo Masters of Science in Bioethics program, was vice-chair of the 16-member Committee Prepositioned Medical Countermeasures for the Public, which...

2011-10-03 13:52:46

As part of preparations for a possible large-scale anthrax attack, public health officials on the state and local levels should determine where and how anthrax-preventing antibiotics should be stored in their communities, says a new report from the Institute of Medicine. The report recommends that state, local, and tribal health officials work with the federal government to assess the benefits and costs of strategies that preposition antibiotics close to or in the hands of people who will...

2011-09-29 05:30:00

WASHINGTON, Sept. 29, 2011 /PRNewswire-USNewswire/ -- October 2011 marks the 10 year anniversary of the anthrax attacks in the United States. The following is a statement from Jeff Levi, Ph.D., Executive Director of the Trust for America's Health (TFAH): (Logo: http://photos.prnewswire.com/prnh/20100204/TFAHLOGO) "All of us at the Trust for America's Health want to take this anniversary to remember those we lost and their loved ones and to commemorate the public health community and...

2011-09-09 08:00:00

ANNAPOLIS, Md., Sept. 9, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) announced today that it has achieved significant progress in the development of its second generation anthrax vaccine, SparVax(TM). In addition to completing initial technology transfer at the 100 liter scale and demonstrating 36 month stability, the Company announced today that it has now completed a 1,500 liter engineering production run for SparVax(TM). As a result, PharmAthene has shown it is able to...

2011-09-09 08:12:00

Recommendations Offered on Future Direction BALTIMORE, Sept. 9, 2011 /PRNewswire-USNewswire/ -- The Center for Biosecurity of UPMC released online ahead of print a new publication, A Crossroads in Biosecurity: Steps to Strengthen U.S. Preparedness, which takes stock of progress since 2001 and makes recommendations for change that would help build resilience and preparedness against biological threats. "Many important government and private sector programs were born in response to the...

2011-09-08 09:00:00

PINE BROOK, N.J., Sept. 8, 2011 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing biodefense countermeasures, announced today that it has been awarded the first U.S. Government contract to develop an anti-toxin for pre- and post-exposure prophylaxis (PEP) use via intramuscular injection (IM). The five year contract, totaling up to $68.9 million, will support multiple animal efficacy studies as well as human safety studies to further demonstrate...

2011-09-01 07:30:00

WASHINGTON, Sept. 1, 2011 /PRNewswire-USNewswire/ -- Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF) released a new report, Remembering 9/11 and Anthrax: Public Health's Vital Role in National Defense, featuring more than 30 firsthand, on-the-ground accounts of public health professionals who were directly involved in the response to the September 11, 2001 and anthrax tragedies. (Logo: http://photos.prnewswire.com/prnh/20100204/TFAHLOGO) The stories...

2011-08-23 17:43:05

Lessons from 2001 anthrax case help pinpoint source of disease Employing technology that reads the entire DNA code, researchers led by the Translational Genomics Research Institute (TGen) and the Technical University of Denmark (DTU) have pinpointed the source of a cholera outbreak in Haiti that killed more than 6,000 people and sickened 300,000. Using whole genome sequencing, which spells out the billions of chemical bases in DNA, TGen and DTU provided the strongest evidence yet that...

2011-07-12 06:00:00

ANNAPOLIS, Md., July 12, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) announced today that it has achieved an important program milestone in its recombinant protective antigen (rPA) anthrax vaccine program and demonstrated 36 month stability of its rPA drug product candidate previously produced at Avecia Biologics Laboratories in the United Kingdom. The stability data were prepared utilizing a variety of analytical methods and a well characterized mouse challenge potency assay....

2011-07-07 00:39:40

An automatic and portable detector that takes just fifteen minutes to analyze a sample suspected of contamination with anthrax is being developed by US researchers. The technology amplifies any anthrax DNA present in the sample and can reveal the presence of just 40 microscopic cells of the deadly bacteria Bacillus anthracis. B. anthracis, commonly known as anthrax, is a potentially lethal microbe that might be used intentionally to infect victims through contamination of food and water...


Latest Anthrax Reference Libraries

11_ca5cd45b16f3d4936fde0520fef6557b
2011-04-14 14:43:25

Bacillus anthracis is a Gram-positive spore-forming, rod-shaped bacterium, with a width of 1-1.2µm and a length of 3-5µm. It can grow in aerobic or anaerobic conditions. It is the only known bacterium to synthesize a protein capsule and the only pathogenic bacterium to carry its own adenylyl cyclase virulence factor. They form oval spores located centrally in a non-swollen sporangium. These spores are highly resilient and can survive extreme temperatures, low-nutrient environments, and...

More Articles (1 articles) »